BlackRock Investment Management’s Sorrento Therapeutics, Inc. SRNE Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2016
Q4 | $510K | Buy |
104,124
+1,207
| +1% | +$5.91K | ﹤0.01% | 3029 |
|
2016
Q3 | $797K | Sell |
102,917
-4,676
| -4% | -$36.2K | ﹤0.01% | 2792 |
|
2016
Q2 | $603K | Buy |
107,593
+6,259
| +6% | +$35.1K | ﹤0.01% | 2943 |
|
2016
Q1 | $545K | Buy |
101,334
+1,714
| +2% | +$9.22K | ﹤0.01% | 2857 |
|
2015
Q4 | $868K | Buy |
99,620
+220
| +0.2% | +$1.92K | ﹤0.01% | 2696 |
|
2015
Q3 | $834K | Sell |
99,400
-1,147
| -1% | -$9.62K | ﹤0.01% | 2726 |
|
2015
Q2 | $1.77M | Buy |
100,547
+96,694
| +2,510% | +$1.7M | ﹤0.01% | 2334 |
|
2015
Q1 | $45K | Buy |
3,853
+58
| +2% | +$677 | ﹤0.01% | 3322 |
|
2014
Q4 | $38K | Sell |
3,795
-150
| -4% | -$1.5K | ﹤0.01% | 3364 |
|
2014
Q3 | $18K | Buy |
3,945
+186
| +5% | +$849 | ﹤0.01% | 3439 |
|
2014
Q2 | $25K | Buy |
+3,759
| New | +$25K | ﹤0.01% | 3339 |
|